SECTION 435:15-11-2. Drug formulary


Latest version.
  • (a)   Physician Assistants in accordance with the Physician Assistant Act may prescribe medications that are within the scope of physician assistant practice, under the supervision of a licensed supervising physician and the Physician Assistant Drug Formulary. The Drug Formulary shall list drugs or categories of drugs that shall or shall not be prescribed by the physician assistant or prescribed only under certain criteria.
    (b)   The Committee will, at least on an annual basis and in a timely manner, review the structure and content of the Physician Assistant Drug Formulary and make such revisions as it deems necessary. Any proposed changes must be reviewed and approved by the State Board of Medical Licensure and Supervision after consultation with the State Board of Pharmacy before becoming effective. Copies of the formulary shall be made available to any licensed pharmacy in the State of Oklahoma upon request. The Board assumes that all supervising physicians and physician assistants are completely familiar with the law and rules governing prescriptive authority of physician assistants.
    (c)   All drugs in categories listed in 435:15-11-2(d) as defined by the American Hospital Formulary Service Information Book (current) may be prescribed by physician assistants, except as noted in section 435:15-11-2(e).
    (d)   Inclusionary formulary
    (1)   Antihistamine agents
    (2)   Anti-infectives
    (3)   Autonomic agents
    (4)   Blood formation and coagulation agents
    (5)   Cardiovascular agents
    (6)   Central nervous system agents
    (7)   Diagnostic agents
    (8)   Electrolyte, caloric and water balance agents
    (9)   Enzymes
    (10)   Expectorants, antitussives and mucolytic agents
    (11)   Eye, ear, nose and throat preparations
    (12)   Gastrointestinal agents
    (13)   Hormone and synthetic substitutes
    (14)   Local anesthetics
    (15)   Skin and mucous membrane agents
    (16)   Smooth muscle relaxants
    (17)   Vitamins
    (18)   Miscellaneous therapeutic agents
[Source: Added at 10 Ok Reg 4377, eff 7-27-93 (emergency); Added at 11 Ok Reg 2331, eff 5-26-94; Amended at 14 Ok Reg 2659, eff 6-26-97; Amended at 16 Ok Reg 378, eff 10-6-98 (emergency); Amended at 16 Ok Reg 1214, eff 5-14-99; Amended at 17 Ok Reg 1353, eff 5-11-00; Amended at 18 Ok Reg 1310, eff 5-11-01; Amended at 18 Ok Reg 3556, eff 8-8-01 through 7-14-02 (emergency); Amended at 20 Ok Reg 16, eff 10-1-02 (emergency); Amended at 20 Ok Reg 2457, eff 7-11-03; Amended at 22 Ok Reg 949, eff 5-12-05; Amended at 33 Ok Reg 946, eff 8-26-16]

Note

EDITOR’S NOTE: Permanent amendments that were intended to supersede this emergency action were published at 19 Ok Reg 2303, with a scheduled effective date of 6-28-02. However, after the permanent amendments were published, the agency reported that the proposed amendments had never been approved by the Governor and should not have been filed for publication in the Register. Because emergency rules effective on or before the first day of a legislative session can only be effective through July 14 following that session (if not already superseded by permanent rules), and because the issuing agency reported that the permanent amendments intended to supersede these emergency amendments should not have been promulgated, the emergency action is cited with a 7-14-02 expiration date. Upon expiration of an emergency action, the last prior permanent text is reinstated. Therefore, on 7-15-02, the text of Section 435:15-11-2 reverted back to the permanent text that became effective 5-11-01 (as last published in the 2001 Edition of the OAC), and remained as such until amended again by emergency action on 10-1-02.